Radiopaque fluorescence-transparent TaOx decorated upconversion nanophosphors for in vivo CT/MR/UCL trimodal imaging

Biomaterials

Volumn 33, Issue 30, 2012, Pages 7530-7539

  Xiao, Qingfeng ^a   Bu, Wenbo ^a   Ren, Qingguo ^b   Zhang, Shengjian ^c   Xing, Huaiyong ^a   Chen, Feng ^a   Li, Ming ^b   Zheng, Xiangpeng ^b   Hua, Yanqing ^b   Zhou, Liangping ^c   Peng, Weijun ^c   Qu, Haiyun ^a   Wang, Zheng ^a   Zhao, Kuaile ^c   Shi, Jianlin ^a  

^a SHANGHAI INSTITUTE OF CERAMICS   (China)

^b FUDAN UNIVERSITY   (China)

^c FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

Author keywords

CT; Magnetic resonance; Tantalum oxide; Trimodal imaging; Upconversion luminescence

Indexed keywords

AVERAGE SIZE; COMBINED EFFECT; CONTRAST ENHANCEMENT; CT; GADOLINIUM IONS; HIGH TRANSPARENCY; IMAGING MODALITY; IN-VITRO; IN-VIVO; INNER CORE; MUTUAL INTERFERENCE; NANOPHOSPHORS; RELAXIVITY; UP-CONVERSION; UP-CONVERSION LUMINESCENCE; WATER-SOLUBLE NANOPARTICLES;

BIOCOMPATIBILITY; FLUORESCENCE; GADOLINIUM; NANOPARTICLES; SYNTHESIS (CHEMICAL); TANTALUM OXIDES; TISSUE;

MAGNETIC RESONANCE;

GADOLINIUM; NANOLITCHI; NANOPARTICLE; OXIDE; TANTALUM OXIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; AQUEOUS SOLUTION; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYTOTOXICITY; FLUORESCENCE IMAGING; IN VIVO STUDY; LUMINESCENCE; MOUSE; NANOPROBE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PRIORITY JOURNAL; UPCONVERSION LUMINESCENCE;

ANIMALS; CELL DEATH; CELL LINE; CONTRAST MEDIA; FLUORESCENCE; HEMOLYSIS; HUMANS; MAGNETIC RESONANCE IMAGING; MICE; MICROSCOPY, CONFOCAL; NANOPARTICLES; OXIDES; SOLUTIONS; TANTALUM; TEMPERATURE; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84864994475     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.06.028     Document Type: Article

References (46)

1. Kalender W.A. X-ray computed tomography. Phys Med Biol 2006, 51:R29-R43.
2. Haller C., Hizoh I. The cytotoxicity of iodinated radiocontrast agents on renal cells in vitro. Invest Radiol 2004, 39:149-154.
3. Hizoh I., Haller C. Radiocontrast-induced renal tubular cell apoptosis-Hypertonic versus oxidative stress. Invest Radiol 2002, 37:428-434.
4. Rabin O., Manuel Perez J., Grimm J., Wojtkiewicz G., Weissleder R. An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles. Nat Mater 2006, 5:118-122.
5. Oh M.H., Lee N., Kim H., Park S.P., Piao Y., Lee J., et al. Large-scale synthesis of bioinert tantalum oxide nanoparticles for X-ray computed tomography imaging and bimodal image-guided sentinel lymph node mapping. J Am Chem Soc 2011, 133:5508-5515.
6. Bonitatibus J.P.J., Torres A.S., Goddard G.D., FitzGerald P.F., Kulkarni A.M. Synthesis, characterization, and computed tomography imaging of a tantalum oxide nanoparticle imaging agent. Chem Commun 2010, 46:8956-8958.
7. Kim D., Park S., Lee J.H., Jeong Y.Y., Jon S. Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging. J Am Chem Soc 2007, 129:7661-7665.
8. Alric C., Taleb J., Duc G.L., Mandon C., Billotey C., Meur-Herland A.L., et al. Gadolinium chelate coated gold nanoparticles as contrast agents for both X-ray computed tomography and magnetic resonance imaging. J Am Chem Soc 2008, 130:5908-5915.
9. Hainfeld J.F., Slatkin D.N., Focella T.M., Smilowitz H.M. Gold nanoparticles: a new X-ray contrast agent. Br J Radiol 2006, 79:248-253.
10. Popovtzer R., Agrawal A., Kotov N.A., Popovtzer A., Balter J., Carey T.E., et al. Targeted gold nanoparticles enable molecular CT imaging of cancer. Nano Lett 2008, 8:4593-4596.
11. Kim Y.-H., Jeon J., Hong S.H., Rhim W.-K., Lee Y.-S., Youn H., et al. Tumor targeting and imaging using cyclic RGD-pegylated gold nanoparticle probes with directly conjugated iodine-125. Small 2011, 7:2052-2060.
12. 4 upconversion nanocrystals via an OA/ionic liquid two-phase system for in vivo dual-modality imaging. Adv Funct Mater 2011, 21:4470-4477.
13. Liu Y., Ai K., Liu J., Yuan Q., He Y., Lu L. A high-performance ytterbium-based nanoparticulate contrast agent for in vivo X-ray computed tomography imaging. Angew Chem Int Ed 2012, 51:1437-1442.
14. 3+ nanoprobe for CT and NIR-to-NIR fluorescent bimodal imaging. Biomaterials 2012, 33:5384-5393.
15. 4:Yb, Er/Tm nanostructure for MRI, CT and upconversion luminescence tri-modality imaging. Biomaterials 2012, 33:4618-4627.
16. Matsuno H., Yokoyama A., Watari F., Uo M., Kawasaki T. Biocompatibility and osteogenesis of refractory metal implants, titanium, hafnium, niobium, tantalum and rhenium. Biomaterials 2001, 22:1253-1262.
17. Black J. Biologic performance of tantalum. Clin Mater 1994, 16:167-173.
18. Findlay D.M., Welldon K., Atkins G.J., Howie D.W., Zannettino A.C.W., Bobyn D. The proliferation and phenotypic expression of human osteoblasts on tantalum metal. Biomaterials 2004, 25:2215-2227.
19. Santra S., Yang H., Holloway P.H., Stanley J.T., Mericle R.A. Synthesis of water-dispersible fluorescent, radio-opaque, and paramagnetic CdS: Mn/ZnS quantum dots: a multifunctional probe for bioimaging. J Am Chem Soc 2005, 127:1656-1657.
20. Wang C., Tao H., Cheng L., Liu Z. Near-infrared light induced in vivo photodynamic therapy of cancer based on upconversion nanoparticles. Biomaterials 2011, 32:6145-6154.
21. 4-based upconversion nanophosphors for high-contrast bioimaging in different animal species. Biomaterials 2012, 33:3733-3742.
22. 3+ doped fluoride nanophosphors. Nano Lett 2008, 8:3834-3838.
23. Cao T., Yang Y., Gao Y., Zhou J., Li Z., Li F. High-quality water-soluble and surface-functionalized upconversion nanocrystals as luminescent probes for bioimaging. Biomaterials 2011, 32:2959-2968.
24. Wang F., Han Y., Lim C.S., Lu Y., Wang J., Xu J., et al. Simultaneous phase and size control of upconversion nanocrystals through lanthanide doping. Nature 2010, 463:1061-1065.
25. 18F-labeled magnetic-upconversion nanophosphors via rare-earth cation-assisted ligand assembly. ACS Nano 2011, 5:3146-3157.
26. Zhou J., Sun Y., Du X., Xiong L., Hu H., Li F. Dual-modality in vivo imaging using rare-earth nanocrystals with near-infrared to near-infrared (NIR-to-NIR) upconversion luminescence and magnetic resonance properties. Biomaterials 2010, 31:3287-3295.
27. 4 nanophosphors for multimodality PET/MR/UCL imaging. Biomaterials 2011, 32:1148-1156.
28. Xing H., Bu W., Zhang S., Zheng X., Li M., Chen F., et al. Multifunctional nanoprobes for upconversion fluorescence, MR and CT trimodal imaging. Biomaterials 2012, 33:1079-1089.
29. Chen F., Bu W., Zhang S., Liu X., Liu J., Xing H., et al. Positive and negative lattice shielding effects co-existing in Gd (III) ion doped bifunctional upconversion nanoprobes. Adv Funct Mater 2011, 21:4285-4294.
30. Hu H., Xiong L., Zhou J., Li F., Cao T., Huang C. Multimodal-luminescence core-shell nanocomposites for targeted imaging of tumor cells. Chem Eur J 2009, 15:3577-3584.
31. Zhang T., Ge J., Hu Y., Yin Y. A general approach for transferring hydrophobic nanocrystals into water. Nano Lett 2007, 7:3203-3207.
32. Sun Y., Sermon P.A., Vong M.S.W. Design of reflective tantala optical coatings using sol-gel chemistry with ethanoic acid catalyst and chelator. Thin Solid Films 1996, 278:135-139.
33. 2-enhanced magnetic resonance and NIR-to-NIR upconversion luminescent imaging of small-animal lymphatic node. Biomaterials 2011, 32:7200-7208.
34. Alvarez-Lorenzo C., Bromberg L., Concheiro A. Light-sensitive intelligent drug delivery systems. Photochem Photobiol 2009, 85:848-860.
35. Zhang G., Liu Y., Yuan Q., Zong C., Liu J., Lu L. Dual modal in vivo imaging using upconversion luminescence and enhanced computed tomography properties. Nanoscale 2011, 3:4365-4371.
36. 4 nanocrystals. Adv Funct Mater 2009, 19:853-859.
37. 4 nanocrystals with improved upconversion fluorescence and MR relaxivity. Nanotechnology 2010, 21:125602.
38. 1 MRI contrast enhancement. Chem Mater 2011, 23:3714-3722.
39. Kato H., Nakamura T., Nishiguchi S., Matsusue Y., Kobayashi M., Miyazaki T., et al. Bonding of alkali- and heat-treated tantalum implants to bone. J Biomed Mater Res 2000, 53:28-35.
40. Sagomonyants K.B., Hakim-Zargar M., Jhaveri A., Aronow M.S., Gronowicz G. Porous tantalum stimulates the proliferation and osteogenesis of osteoblasts from elderly female patients. J Orthop Res 2011, 29:609-616.
41. Sharma C.P., Paul W. Protein-interaction with tantalum - changes with oxide layer and hydroxyapatite at the interface. J Biomed Mater Res 1992, 26:1179-1184.
42. Shtansky D.V., Gloushankova N.A., Bashkova I.A., Kharitonova M.A., Moizhess T.G., Sheveiko A.N., et al. Ta-doped multifunctional bioactive nanostructured films. Surf Coat Technol 2008, 202:3615-3624.
43. Balla V.K., Bose S., Davies N.M., Bandyopadhyay A. Tantalum-a bioactive metal for implants. JOM 2010, 62:61-64.
44. Blanco J.F., Sanchez-Guijo F.M., Carrancio S., Muntion S., Garcia-Brinon J., del Canizo M.C. Titanium and tantalum as mesenchymal stem cell scaffolds for spinal fusion: an in vitro comparative study. Eur Spine J 2011, 20:353-360.
45. Slowing I.I., Wu C.W., Vivero-Escoto J.L., Lin V.S.Y. Mesoporous silica nanoparticles for reducing hemolytic activity towards mammalian red blood cells. Small 2009, 5:57-62.
46. Lin Y.-S., Haynes C.L. Impacts of mesoporous silica nanoparticle size, pore ordering, and pore integrity on hemolytic activity. J Am Chem Soc 2010, 132:4834-4842.